Register

Regulatory news analysis / United States

Page Searcher
Territory
Topics
Content type

2016 in e-cigarettes – rapid change, new regulation, and some shocks

30 December, 2016 | Regulatory news analysis |

Asia
Australasia
Australia
Canada
China
Denmark
England
EU
Europe
Germany
Indonesia
Japan
Malaysia
North America
Philippines
United Kingdom
United States
Vietnam
Wales
World
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Regulatory news analysis

May 2016 brought the two biggest regulatory developments in the short history of the e-cigarette so far. But the U.S. deeming regulations and European TPD were far from the only stories brought to you by ECigIntelligence in another year of rapid change…

FDA rejects snus as modified risk – but could reconsider some aspects

14 December, 2016 | Regulatory news analysis |

Europe
North America
Norway
Sweden
United States
Companies
Marketing and Retailing
Public Health and Medicine
Regulation and Legislation
Regulatory news analysis

Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus products classified as modified risk – and they mix outright rejections with some very mild encouragement.

Surgeon general criticised and praised over youth vaping report

9 December, 2016 | Regulatory news analysis |

North America
United States
Policy and Politics
Public Health and Medicine
Regulatory news analysis

U.S. Surgeon General Vivek Murthy’s report on the use of e-cigarettes by young people has drawn both criticism and praise. Representatives of the industry claimed the report ignored the benefits e-cigarettes can provide to those trying to avoid cigarettes, while medical groups and other organisations praised it and its call
for action.

PMI bids to gain first ever FDA modified-risk approval for iQOS

6 December, 2016 | Regulatory news analysis |

North America
United States
Companies
Marketing and Retailing
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Regulatory news analysis

Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA), a strategy which if successful would provide a tremendous boost to the credibility of heat-not-burn and perhaps pave the way for PMI’s partner Altria to dominate that market in the United States.

Pyrrhic lawmaking - Art Gallery Ergsart

Indiana legislators vow to change e-liquid security requirements

1 December, 2016 | Regulatory news analysis |

Indiana
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory news analysis

Indiana law-makers have promised to replace the state’s controversial e-liquid manufacturing law during the next legislative session. The law specifies security requirements for e-liquid makers which most have not been able to achieve. The Republican party, which holds the majority in the Indiana state senate, has promised to address the law during the next session at its official […]

Smoking ban, -public policy and vaping - Elvert Barnes

Public vaping bans can be bad for your health, researchers warn

22 November, 2016 | Regulatory news analysis |

England
Europe
North America
Northern Ireland
Scotland
United Kingdom
United States
Wales
Policy and Politics
Public Health and Medicine
Regulatory news analysis

Public vaping bans run contrary to best science and may have negative effects on public health, undermining efforts to combat smoking, according to a report by several leading academics.

With Trump in the White House, is Cole-Bishop necessary?

18 November, 2016 | Regulatory news analysis |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory news analysis

While many in the U.S. e-cigarette world hope that the Cole-Bishop proposal to change the FDA’s grandfathering date could be the industry’s salvation, at least one commentator believes it should be abandoned in the light of Donald Trump’s election to the presidency.